GSK vs SPFI · P/E 13, $103.31B cap vs P/E 12, rev $137.6M
GlaxoSmithKline PLC ADR (GSK) versus South Plains Financial Inc (SPFI) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
South Plains Financial Inc (SPFI) is a banks - regional company listed on NASDAQ.
GSK does not have a complete income-statement cache yet.
Latest reported SPFI revenue for 2026-06-30 was $137.6M. Net income was $33.5M. SPFI currently screens at market cap $792.4M and trailing P/E 11.6.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. SPFI currently screens at market cap $792.4M and trailing P/E 11.6.
Not investment advice. Open the GSK and SPFI stock pages for the full models.
Not investment advice.